Jump to content

Rosalind Eeles

From Wikipedia, the free encyclopedia

This is the current revision of this page, as edited by Jevansen (talk | contribs) at 10:19, 7 April 2024 (Moving from Category:Cancer researchers to Category:British cancer researchers using Cat-a-lot). The present address (URL) is a permanent link to this version.

(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)

Rosalind Eeles
Alma mater
Scientific career
FieldsOncogenetics, Cancer genetics
Institutions
Thesis Germline and Somatic Mutations in the TP53 Gene in Breast and Other Cancers  (2000)
Scholia has a profile for Rosalind Eeles (Q24640445).

Rosalind Anne Eeles is a Professor of Oncogenetics at the Institute of Cancer Research and clinician at the Royal Marsden NHS Foundation Trust. She is a leader in the field of genetic susceptibility to prostate cancer, and is known for the discovery of 14 genetic variants involved in prostate cancer predisposition.[1] According to ResearchGate, Eeles has published more than 500 articles in peer-reviewed journals, with over 34,000 citations and an h-index of 92.[2] Eeles was elected a Fellow of the Academy of Medical Science in 2012.[1] She was awarded a National Institute for Health Research Senior Investigator Emeritus in 2014.[3][4]

Education[edit]

Eeles completed her medical training at the University of Cambridge and St Thomas' Hospital Medical School, and trained in Clinical Oncology at The Royal Marsden NHS Foundation Trust.[5] She completed a PhD in cancer genetics at the Institute of Cancer Research, finishing her thesis in 2000.[6]

Research[edit]

Eeles' research is focussed on the genetic causes of prostate cancer and identifying patients with increased risk of developing the disease.[7] She leads a UK clinical trial investigating the impact of regular screening for patients with increased risk of prostate cancer due to BRCA mutations.[8] Eeles also established PRACTICAL, an international consortium that allows researchers to share genetic data from prostate cancer patients. Her research group are part of the International Cancer Genome Consortium (ICGC).[9]

Selected works[edit]

  • Magali Olivier; Rosalind Eeles; Monica Hollstein; Mohammed A Khan; Curtis C Harris; Pierre Hainaut (1 June 2002). "The IARC TP53 database: new online mutation analysis and recommendations to users". Human Mutation. 19 (6): 607–614. doi:10.1002/HUMU.10081. ISSN 1059-7794. PMID 12007217. Wikidata Q43714274.
  • Rosalind A Eeles; Zsofia Kote-Jarai; Graham G Giles; et al. (March 2008). "Multiple newly identified loci associated with prostate cancer susceptibility". Nature Genetics. 40 (3): 316–21. doi:10.1038/NG.90. ISSN 1061-4036. PMID 18264097. Wikidata Q28268180.
  • Rosalind A Eeles; Zsofia Kote-Jarai; Ali Amin Al Olama; et al. (20 September 2009). "Identification of seven new prostate cancer susceptibility loci through a genome-wide association study". Nature Genetics. 41 (10): 1116–1121. doi:10.1038/NG.450. ISSN 1061-4036. PMC 2846760. PMID 19767753. Wikidata Q29417022. {{cite journal}}: |author101= has generic name (help)
  • Mahbubl Ahmed; Chee Goh; Edward Saunders; Clara Cieza-Borrella; PRACTICAL consortium; Zsofia Kote-Jarai; Fredrick R Schumacher; Rosalind Eeles (27 November 2019). "Germline genetic variation in prostate susceptibility does not predict outcomes in the chemoprevention trials PCPT and SELECT". Prostate Cancer and Prostatic Diseases. doi:10.1038/S41391-019-0181-Y. ISSN 1365-7852. PMID 31776447. Wikidata Q91496974.
  • Elizabeth K. Bancroft; Kelly Kohut; Rosalind Eeles (3 February 2020). "The New Genomics Era: Integration of genomics into mainstream oncology and implications for psycho-oncological care". Psycho-Oncology. 29 (3): 453–460. doi:10.1002/PON.5331. ISSN 1057-9249. PMID 32017261. Wikidata Q89525325.

References[edit]

  1. ^ a b "Professor Rosalind Eeles | The Academy of Medical Sciences". acmedsci.ac.uk. Retrieved 23 May 2019.
  2. ^ "Ros Eeles". ResearchGate. Retrieved 24 May 2019.
  3. ^ "Senior Investigators". si.gmg-is.co.uk. Retrieved 24 May 2019.
  4. ^ "ORCID". orcid.org. Retrieved 24 May 2019.
  5. ^ "Prof. Ros Eeles - AcademiaNet". www.academia-net.org. Retrieved 24 May 2019.
  6. ^ Eeles, Rosalind Anne (2000). Germline and somatic studies in the TP53 gene in breast and other cancers (Ph.D. thesis). Institute of Cancer Research (University Of London).
  7. ^ "Professor Rosalind Eeles". Cancer Research UK. 15 March 2017. Retrieved 24 May 2019.
  8. ^ "The IMPACT Study - Identification of Men With a Genetic Predisposition to ProstAte Cancer - Full Text View - ClinicalTrials.gov". clinicaltrials.gov. Retrieved 24 May 2019.
  9. ^ "United Kingdom - Prostate Cancer |". icgc.org. Retrieved 24 May 2019.

External links[edit]

Retrieved from "https://en.wikipedia.org/w/index.php?title=Rosalind_Eeles&oldid=1217699025"